MICHAEL ITTMANN to Molecular Targeted Therapy
This is a "connection" page, showing publications MICHAEL ITTMANN has written about Molecular Targeted Therapy.
Connection Strength
0.136
-
Targeting the TMPRSS2/ERG fusion mRNA using liposomal nanovectors enhances docetaxel treatment in prostate cancer. Prostate. 2020 01; 80(1):65-73.
Score: 0.085
-
Targeting fibroblast growth factor receptor signaling inhibits prostate cancer progression. Clin Cancer Res. 2012 Jul 15; 18(14):3880-8.
Score: 0.051